Caplin Point Laboratories Limited
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and spray… Read more
Caplin Point Laboratories Limited (CAPLIPOINT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.079x
Based on the latest financial reports, Caplin Point Laboratories Limited (CAPLIPOINT) has a cash flow conversion efficiency ratio of 0.079x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹2.54 Billion) by net assets (₹31.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Caplin Point Laboratories Limited - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Caplin Point Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Caplin Point Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Caplin Point Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ag Growth International Inc
PINK:AGGZF
|
-0.004x |
|
Tsukishima Holdings Co., Ltd.
F:QO3
|
N/A |
|
Triductor Technology (Suzhou) Inc.
SHG:688259
|
0.022x |
|
Shenzhen Hifuture Electric
SHE:002168
|
-0.399x |
|
Shaanxi Xinghua Chemistry Co Ltd
SHE:002109
|
-0.015x |
|
Sung Kwang Bend Co.Ltd
KQ:014620
|
0.036x |
|
Card Factory plc
PINK:CRFCF
|
0.071x |
|
Kunshan Asia Aroma Corp. Ltd.
SHE:301220
|
0.002x |
Annual Cash Flow Conversion Efficiency for Caplin Point Laboratories Limited (2007–2025)
The table below shows the annual cash flow conversion efficiency of Caplin Point Laboratories Limited from 2007 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹28.86 Billion | ₹4.32 Billion | 0.150x | +10.41% |
| 2024-03-31 | ₹23.47 Billion | ₹3.18 Billion | 0.136x | -4.75% |
| 2023-03-31 | ₹19.07 Billion | ₹2.72 Billion | 0.142x | -36.14% |
| 2022-03-31 | ₹15.10 Billion | ₹3.37 Billion | 0.223x | +0.98% |
| 2021-03-31 | ₹12.03 Billion | ₹2.66 Billion | 0.221x | +372.88% |
| 2020-03-31 | ₹9.57 Billion | ₹446.77 Million | 0.047x | -64.56% |
| 2019-03-31 | ₹6.33 Billion | ₹834.25 Million | 0.132x | -27.85% |
| 2018-03-31 | ₹3.64 Billion | ₹664.82 Million | 0.183x | -39.51% |
| 2017-03-31 | ₹2.25 Billion | ₹678.22 Million | 0.302x | -8.11% |
| 2016-03-31 | ₹1.36 Billion | ₹446.08 Million | 0.329x | -38.42% |
| 2015-03-31 | ₹934.61 Million | ₹498.83 Million | 0.534x | -39.82% |
| 2014-03-31 | ₹619.16 Million | ₹549.16 Million | 0.887x | +20.01% |
| 2013-03-31 | ₹432.35 Million | ₹319.52 Million | 0.739x | -10.99% |
| 2012-03-31 | ₹336.31 Million | ₹279.24 Million | 0.830x | +70.80% |
| 2011-03-31 | ₹291.13 Million | ₹141.53 Million | 0.486x | +4441.00% |
| 2010-03-31 | ₹254.36 Million | ₹2.72 Million | 0.011x | -97.90% |
| 2009-03-31 | ₹238.66 Million | ₹121.67 Million | 0.510x | +893.50% |
| 2008-03-31 | ₹216.40 Million | ₹11.10 Million | 0.051x | -64.28% |
| 2007-03-31 | ₹139.90 Million | ₹20.10 Million | 0.144x | -- |